Browsing byAuthor성주명

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 78 to 102 of 102

Issue DateTitleAuthor(s)Type
2009Reactive Oxygen Species Might Have Important Roles On Angiogenesis of Endothelial Progenitor Cells Derived From HCB(Human Cord Blood) Which Are Stimulated by VEGF.성주명; 유은선; 이경은; 문영철; 남은미Meeting Abstract
2007Restoration of peroxiredoxins and catalase is closely correlated with the level of Philadelphia chromosome during imatinib therapy in CML성주명; 이서구; 유은선; 허정원; 이경은; 문영철; 우현애Meeting Abstract
2013RESTORATION OF REDOX ENZYMES IS CORRELATED WITH REDUCTION OF BCR-ABL PROTEIN IN PHILADELPHIA POSITIVE CELLS DURING IMATINIB THERAPY성주명; 유은선; 허정원; 문영철Meeting Abstract
2012Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or -intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party성주명Meeting Abstract
2012Ring Chromosome 5 in acute myeloid leukemia defned by whole-genome single nucleotide polymorphism array정화순; 성주명; 허정원; 문영철Article
2008Risk factors of radiation pneumonitis in lung cancer성주명; 이경은; 문영철Meeting Abstract
2022Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea성주명Article
2008Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial성주명Meeting Abstract
2007Sequential VAD (vincristine, adriamycin, dexamethasone) and VTD (VELCADE (R), thalidomide, dexamethasone) induction followed by high-dose therapy with autologous stem cell transplantation and maintenance treatment with VELCADE for newly diagnosed multiple myeloma: Interim results of phase II trial성주명Meeting Abstract
2012Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: Results of a phase II trial성주명Article
2005Signaling mechanisms of anti-proliferation by sphingosine 1-phoshate (S1P) on acute promyelocytic leukaemia cell lines성주명; 문영철Meeting Abstract
2013Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality정화순; 성주명; 허정원; 문영철Article
2011Single nucleotide polymorphism array-based karyotyping shows sequential genomic changes from monosomy to copy-neutral loss of heterozygosity of chromosome 7 and 20q deletion within a balanced translocation t(14;20) in AML정화순; 성주명; 허정원; 문영철Article
2015Submicroscopic Deletions of Immunoglobulin Heavy Chain Gene (IGH) in Precursor B Lymphoblastic Leukemia with IGH Rearrangements정화순; 성주명; 유은선; 허정원; 문영철Article
2006The intention to treat analysis of the different post remission therapy modalities in AML patients with the "Intermediate Risk Group (IPG)" based on cytogenetics.성주명; 문영철Meeting Abstract
2009The Level of Peroxiredoxin and Catalase On Single Cell Level Is Correlated with the Positivity of Ph Chromosome in the Bone Marrow of CML Patients During Imatinib Therapy.성주명; 이서구; 유은선; 허정원; 이경은; 문영철; 남은미; 우현애Meeting Abstract
2006The LTB4 receptor is involved not only in the downstream pathway of rhG-CSF mobilization but in the LTB4 mobitization pathway in C57BL/6 mice.이순남; 성주명; 유은선; 이경은; 문영철Meeting Abstract
2014Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer이순남; 성순희; 성주명; 이경은; 문영철; 남은미Article
2003Transepithelial migration of neutrophils in response to leukotriene B4 is mediated by a reactive oxygen species-extracellular signal-regulated kinase-linked cascade성주명; 문영철Article
2010Unsorted human adipose tissue-derived stem cells promote angiogenesis and myogenesis in murine ischemic hindlimb model성주명; 권기환Article
2017VARIABLE NATURAL KILLER CELL ACTIVITY IN HEMATOLOGIC MALIGNANCIES AT DIAGNOSIS성주명; 허정원; 문영철Meeting Abstract
2010Variant Philadelphia chromosome identified by interphase fluorescence in situ hybridization (FISH) without evidence on G-banded karyotyping and metaphase FISH정화순; 성주명; 허정원; 문영철Article
2011Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia정화순; 성주명; 허정원; 문영철Article
2008Velcade (R), Thalidomide, Dexamethasone (VTD) Followed by Melphalan, Prednisone, Thalidomide (MPT) Maintenance as a First Line Treatment Demonstrates High Response Rates for High-Risk Patients with Multiple Myeloma (MM) Who Are Non-Transplant Candidates: Updated Results of Phase II Trial.성주명Meeting Abstract
2007Velcade (R), thalidomide, dexamethasone (VTD) induction therapy followed by melphalan, prednisone, thalidomide (MPT) maintenance as a first line treatment for the patients (pts) with multiple myeloma (MM) who are non-transplant candidates: Early analysis from the Korean multiple myeloma working party성주명Meeting Abstract

BROWSE